DK1296651T3 - Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat - Google Patents
Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparatInfo
- Publication number
- DK1296651T3 DK1296651T3 DK01947612T DK01947612T DK1296651T3 DK 1296651 T3 DK1296651 T3 DK 1296651T3 DK 01947612 T DK01947612 T DK 01947612T DK 01947612 T DK01947612 T DK 01947612T DK 1296651 T3 DK1296651 T3 DK 1296651T3
- Authority
- DK
- Denmark
- Prior art keywords
- particles
- preparation
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 239000002245 particle Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Otolaryngology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00113608 | 2000-06-27 | ||
| GB0029263A GB0029263D0 (en) | 2000-11-30 | 2000-11-30 | Method of making particles for use in a pharmaceutical composition |
| PCT/GB2001/001732 WO2001078694A2 (en) | 2000-04-17 | 2001-04-17 | Formulations for use in inhaler devices |
| PCT/GB2001/002860 WO2002000197A1 (en) | 2000-06-27 | 2001-06-27 | Method of making particles for use in a pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1296651T3 true DK1296651T3 (da) | 2008-02-11 |
Family
ID=27223055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01947612T DK1296651T3 (da) | 2000-06-27 | 2001-06-27 | Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP5698423B2 (enrdf_load_stackoverflow) |
| AU (2) | AU2001269261B2 (enrdf_load_stackoverflow) |
| CA (1) | CA2413692C (enrdf_load_stackoverflow) |
| DE (1) | DE60131399T3 (enrdf_load_stackoverflow) |
| DK (1) | DK1296651T3 (enrdf_load_stackoverflow) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5288791B2 (ja) * | 2005-01-28 | 2013-09-11 | 武田薬品工業株式会社 | 難水溶性物質含有微細化組成物 |
| ITMI20051999A1 (it) | 2005-10-21 | 2007-04-22 | Eratech S R L | Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' |
| PT2560611T (pt) * | 2010-04-21 | 2018-02-07 | Chiesi Farm Spa | Processo para proporcionar partículas com cargas eletrostáticas reduzidas |
| RU2666963C2 (ru) * | 2012-04-13 | 2018-09-13 | Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Агрегированные частицы |
| EP3019153B1 (en) * | 2013-07-11 | 2018-09-05 | Chiesi Farmaceutici S.p.A. | Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation |
| MA40910A (fr) * | 2014-11-07 | 2017-09-12 | Civitas Therapeutics Inc | Poudres de rapamycine pour administration pulmonaire |
| WO2019009335A1 (ja) * | 2017-07-04 | 2019-01-10 | 村上 正裕 | 微粒子の製造方法及び微粒子 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1204826B (it) * | 1986-03-04 | 1989-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche per inalazione |
| SE8603812D0 (sv) * | 1986-09-12 | 1986-09-12 | Draco Ab | Administration of liposomes to mammals |
| DE3917617A1 (de) * | 1989-05-31 | 1990-12-06 | Boehringer Ingelheim Kg | Mikronisierte bioabbaubare partikel, verfahren zur ihrer herstellung und ihre verwendung |
| GB2269992A (en) * | 1992-08-14 | 1994-03-02 | Rh Ne Poulenc Rorer Limited | Powder inhalation formulations |
| GB9501841D0 (en) * | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| GB9515182D0 (en) * | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
| ATE287257T1 (de) * | 1997-01-16 | 2005-02-15 | Massachusetts Inst Technology | Zubereitung von partikelhaltigen arzneimitteln zur inhalation |
| DE69918074T2 (de) * | 1998-03-26 | 2004-11-04 | Fujisawa Pharmaceutical Co., Ltd. | Makrolid-formulierung mit verzögerter wirkstoffabgabe |
| CA2347856C (en) * | 1998-11-13 | 2009-02-17 | Jago Research Ag | Dry powder for inhalation |
| GB9826783D0 (en) * | 1998-12-04 | 1999-01-27 | Scherer Ltd R P | Inhalation powders |
| GB9827145D0 (en) * | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
-
2001
- 2001-06-27 CA CA2413692A patent/CA2413692C/en not_active Expired - Lifetime
- 2001-06-27 AU AU2001269261A patent/AU2001269261B2/en not_active Expired
- 2001-06-27 DK DK01947612T patent/DK1296651T3/da active
- 2001-06-27 AU AU6926101A patent/AU6926101A/xx active Pending
- 2001-06-27 JP JP2002504979A patent/JP5698423B2/ja not_active Expired - Lifetime
- 2001-06-27 DE DE60131399.2T patent/DE60131399T3/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2413692C (en) | 2011-10-18 |
| JP5698423B2 (ja) | 2015-04-08 |
| CA2413692A1 (en) | 2002-01-03 |
| DE60131399T3 (de) | 2019-11-14 |
| AU2001269261B2 (en) | 2005-11-17 |
| DE60131399D1 (de) | 2007-12-27 |
| JP2004501183A (ja) | 2004-01-15 |
| DE60131399T2 (de) | 2008-04-17 |
| AU6926101A (en) | 2002-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1296656T3 (da) | Fremgangsmåde til fremstilling af et præparat | |
| AU2211502A (en) | Method of making particles for use in a pharmaceutical composition | |
| DK1158992T3 (da) | Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer | |
| DE60106623D1 (de) | Neue pharmazeutische zusammensetzung | |
| DK1349580T4 (da) | Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning | |
| EE05378B1 (et) | LahustuvaÁCTLA4ÁsulandmolekuliÁkasutamineÁravimkoostiseÁvalmistamiseks | |
| DE60142197D1 (de) | Pharmazeutische Zusammensetzung | |
| ATE404180T1 (de) | Geschmacksmaskierte pharmazeutische partikel | |
| HUP0303078A3 (en) | Cyclic peptidies process for their preparation pharmaceutical compositions containing them and their use | |
| AT7729U3 (de) | Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat | |
| NO20025450L (no) | Ny farmasöytisk sammensetning | |
| DK1275387T3 (da) | Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed | |
| DK1383482T3 (da) | Fremgangsmåde til fremstilling af en farmaceutisk lavdoseringssammensætning | |
| DK1309545T3 (da) | Fremgangsmåde til fremstilling af alkylarylsulfonater | |
| HUP0302130A3 (en) | Combination pharmaceutical compositions and process for their preparation | |
| HUP0300539A3 (en) | New pharmaceutical composition in form of emulsion preconcentrate | |
| ATE366128T1 (de) | Pharmazeutische zusammensetzung | |
| ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
| DK1296651T3 (da) | Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat | |
| DK1326836T3 (da) | Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin | |
| ATE222586T1 (de) | Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| IL153487A0 (en) | Pharmaceutical compositions and methods for use | |
| DK1171444T3 (da) | Pyridothienodiazepiner, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse | |
| IL153897A0 (en) | Pharmaceutical compositions and methods for use | |
| EE200100607A (et) | Farmatseutiline kompositsioon granulaadi kujul jaselle valmistamismeetod |